More  :
All Resources
Fitness Videos
Fitness Models
How to Go Green
Healthy Recipies
Muscle Beach
Environmental Health
Evaluations
Ergonomics
Free Vitamins
Health Shop
Equipment Reviews
Diet Reviews
Sleeping
Supplement Reviews
Walking Programs
Weight Loss or Gain
|
Source: Associated Press
Summary:
Each year about 800,000 women are diagnosed with early breast cancer and about three-fourths may benefit from Femara, a drug used for advanced breast cancer which is now approved for post-menopausal women who have had early breast cancer.
According to a study in the New England Journal of Medicine, Femara blocks the production of estrogen, a hormone that fuels most tumor growths that develop after menopause.
8,000 subjects were studied over approximately 2 years and show that 84 percent of those women given Femara would be alive without any signs of cancer five years after starting the treatment.
Conclusion: Post menopausal women who have had breast cancer may benefit from switching from Tamoxifen to Femara to prevent breast cancer relapse.
...More Health News, Fitness Headlines
|
